Glenmede Trust’s STAAR Surgical STAA Stock Holding History

Glenmede Trust’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,503	Closed	-$247K	–	1337
2022 Q3	$247K	Buy	+3,503	New	+$300K	﹤0.01%	1023
2020 Q4	–	Sell	-8	Closed	–	–	2118
2020 Q3	$0	Sell	8 -34	-81%	-$1.83K	﹤0.01%	2577
2020 Q2	$2K	Buy	+42	New	+$1.72K	﹤0.01%	2269
2014 Q3	–	Sell	-100	Closed	-$1K	–	2510
2014 Q2	$1K	Hold	100	–	–	﹤0.01%	2286
2014 Q1	$1K	Buy	+100	New	+$1.61K	﹤0.01%	2295

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

EFM

E Fund Management Guangzhou, China $3.37B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Glenmede Trust's STAA Position: Q4 2022 in Review

Glenmede Trust sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 3,503 shares — an estimated $247K sold.

Glenmede Trust first reported a position in STAA in Q1 2014 and held it in 5 quarters. The position peaked at $247K in Q3 2022. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

Glenmede Trust reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
Glenmede Trust sold 3,503 STAAR Surgical shares in Q4 2022, an estimated $247K.
Glenmede Trust first reported a position in STAAR Surgical in Q1 2014 and held it in 5 quarters.
Glenmede Trust's STAAR Surgical position peaked at $247K in Q3 2022.
275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on Glenmede Trust's 13F filing for Q4 2022, filed 14 Feb 2023.